NCT01261143View on ClinicalTrials.gov

Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

April 30, 2012

Conditions
Diabetic Neuropathies
Interventions
DRUG

BK-C-0701

tablet, 8 weeks

Trial Locations (1)

Unknown

Kyung soo Ko, Seoul

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY

NCT01261143 - Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy | Biotech Hunter | Biotech Hunter